Completed

Study to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe

Clinicaltrials.gov Identifier: 

nct03767738

Trial details

Trial date:
December 19, 2018 - August 19, 2020
Phase:  4
Birth sex
Male and female gender symbols.
Age range
18 Years and Older
Accepts healthy volunteers
No
Condition(s) being studied: 

Chorioretinal Vascular Disease

What is the type of trial? 

Interventional

What is the trial testing? 

Intravitreal Aflibercept Injection (IAI)

How many people are being enrolled? 

65

Trial summary

The primary objective of the study is to determine if the pre-filled syringe (PFS) supports successful preparation and accurate administration of an aflibercept injection.

The secondary objective of the study is to assess ocular safety in the study eye.

Trial locations

0 location(s)